Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Mc-val-cit-pab-indibulin | 2055896-95-0 | MFCD32201121 | 95.8% | 945.49 g/mol | C50H55ClN9O8+ | 50 MG
SDP

Catalog No. 5000202639
Encompass_Preferred

MC-Val-Cit-PAB-Indibulin is an antibody-drug conjugate (ADC) drug-linker conjugate in which the tubulin inhibitor indibulin is attached via a cleavable MC-Val-Cit-PAB linker. It is intended for research use in ADC development and preclinical studies.

  • Provides an indibulin payload linked through a protease-cleavable Val-Cit spacer
  • Offers a maleimidocaproyl (MC) reactive handle for thiol conjugation
  • Suitable for antibody-drug conjugate synthesis and preclinical evaluation
  • Reported purity suitable for research applications
  • Available in multiple milligram-scale package sizes for development needs

Catalog No. 50-002-02639 Supplier Medchemexpress LLC Supplier No. HY12890850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MC-Val-Cit-PAB-Indibulin is an antibody-drug conjugate (ADC) drug-linker conjugate in which the tubulin inhibitor indibulin is attached via a cleavable MC-Val-Cit-PAB linker. It is intended for research use in ADC development and preclinical studies.

  • Provides an indibulin payload linked through a protease-cleavable Val-Cit spacer
  • Offers a maleimidocaproyl (MC) reactive handle for thiol conjugation
  • Suitable for antibody-drug conjugate synthesis and preclinical evaluation
  • Reported purity suitable for research applications
  • Available in multiple milligram-scale package sizes for development needs

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.